Pharmaceuticals

Global Natural Killer (NK) Cell Therapeutics Market Trends and Growth Analysis 2025–2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Anticipated Size Of The Natural Killer (NK) Cell Therapeutics Market Over The Five-Year Period 2025–2029?

The natural killer (NK) cell therapeutics market size has seen rapid expansion in recent years. It is anticipated to increase from $3.52 billion in 2024 to $3.93 billion in 2025, growing at a compound annual growth rate (CAGR) of 11.6%. The expansion observed in the past can be attributed to a rise in cancer incidence, increased R&D funding, growing awareness of immunotherapy, an increase in strategic industry partnerships, enhanced regulatory support, and improvements in cell expansion technologies.

The natural killer (NK) cell therapeutics market is projected for substantial expansion in the coming years, expected to reach “$6.17 billion in 2029, exhibiting a compound annual growth rate (CAGR) of 12.0%. This anticipated growth during the forecast period is primarily driven by an increase in clinical trials, rising investment in immunotherapy research and development, expanding applications in solid tumors, strategic collaborations, robust regulatory support for cell therapies, and growing patient demand for personalized cancer treatments. Key trends anticipated in the forecast period include innovations in genetic engineering, improved CAR-NK therapies, enhanced cell expansion techniques, novel developments in clinical trial activity, the creation of off-the-shelf NK cell products, and advancements in solid tumor treatments.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24328&type=smp

Which Factors And Drivers Are Influencing The Natural Killer (NK) Cell Therapeutics Market In 2025?

The increasing occurrence of cancer is anticipated to propel the expansion of the natural killer (NK) cell therapeutics market in the coming years. Cancer encompasses a range of diseases where abnormal cells multiply uncontrollably, invade adjacent tissues, and spread throughout the body, disrupting normal cellular regulation, leading to tumor formation, and impairing bodily functions. Environmental factors such as exposure to pollutants, tobacco smoke, and chemicals can damage deoxyribonucleic acid (DNA) and interfere with cellular function, thereby raising the risk of cancer. Natural killer (NK) cell therapeutics aid in treating cancer by directly identifying and eliminating tumor cells without needing prior sensitization. For instance, in April 2024, the American Cancer Society, a US-based non-profit organization, reported that in 2022, 20 million new cancer cases were diagnosed and 9.7 million individuals worldwide succumbed to the disease. It is projected that by 2050, the number of cancer cases will climb to 35 million, based purely on forecasted population growth. Thus, the escalating prevalence of cancer is a significant factor driving the growth of the natural killer (NK) cell therapeutics market.

Which Key Segments Fueling The Natural Killer (NK) Cell Therapeutics Market?

The natural killer (nk) cell therapeutics market covered in this report is segmented –

1) By Therapeutics: Natural Killer (NK) Cell Directed Antibodies, Natural Killer (NK) Cell Therapies

2) By Application: Immunoproliferative Disorders, Gastrointestinal Diseases, Cancer, Other Applications

3) By Distribution Channel: Hospital Pharmacies, Direct Tender, Other Distribution Channels

4) By End User: Research And Academic Institutes, Hospitals, Specialty Clinics

Subsegments:

1) By Natural Killer (NK) Cell Directed Antibodies: Monoclonal Antibodies (mAbs), Bispecific Antibodies (BsAbs), Antibody-Drug Conjugates (ADCs)

2) By Natural Killer (NK) Cell Therapies: Autologous NK Cell Therapies, Allogeneic NK Cell Therapies, Chimeric Antigen Receptor (CAR)-NK Cell Therapies

How Are Emerging Market Trends Shaping The Natural Killer (NK) Cell Therapeutics Industry Landscape?

Leading companies within the natural killer (NK) cell therapeutics market are prioritizing advancements, such as developing scalable manufacturing platforms based on iPSCs for NK cells, with the goal of enabling cost-effective, readily available NK cell treatments. These platforms utilize induced pluripotent stem cells (iPSCs) to generate NK cells in a standardized, feeder-free, and closed-system bioreactor environment, thereby ensuring high yields and regulatory compliance. For example, in April 2025, Cellistic, a biotechnology research company from Belgium, introduced its Echo-NK platform, an iPSC-based solution for manufacturing NK cell therapies. This platform allows for the scalable production of NK cells targeting blood cancers, solid tumors, and autoimmune diseases, with all crucial expansion steps conducted within closed-system bioreactors at Cellistic’s EMA-certified GMP facility. Through the integration of Cellistic’s Pulse cell line development capabilities and its proprietary STAR-CRISPR technology, the Echo-NK platform expedites the development of stable iPSC cell lines with specific gene edits, offering a commercially viable option for off-the-shelf NK cell therapies.

Who Are The Key Multinational Companies Dominating The Natural Killer (NK) Cell Therapeutics Market?

Major companies operating in the natural killer (NK) cell therapeutics market are Sanofi S.A., Thermo Fisher Scientific, Lonza AG, Catalent, Kite Pharma, Fate Therapeutics, Artiva Biotherapeutics, Nkarta, Inc, Celularity Inc., NKGen Biotech, Dragonfly Therapeutics, Cytovia Therapeutics, Glycostem Therapeutics, Gamida Cell, ONK Therapeutics, Wugen Inc., AGC Biologics, CytoImmune Therapeutics, XNK Therapeutics, Indapta Therapeutics, Neukio Biotherapeutics, Senti Biosciences, WuXi Advanced Therapies, Kiadis Pharma

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/natural-killer-nk-cell-therapeutics-global-market-report

Which Regional Markets Are Contributing Most To The Natural Killer (NK) Cell Therapeutics Industry Expansion?

North America was the largest region in the natural killer (NK) cell therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the natural killer (NK) cell therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Natural Killer (NK) Cell Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24328&type=smp

Browse Through More Reports Similar to the Global Natural Killer (NK) Cell Therapeutics Market 2025, By The Business Research Company

Natural Antioxidants Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/natural-antioxidants-global-market-report

Natural Cosmetics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/natural-cosmetics-global-market-report

Natural Fibers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/natural-fibers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795